KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutanix (NTNX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Nutanix (NTNX) over the last 11 years, with Q4 2025 value amounting to $22.3 million.

  • Nutanix's Capital Expenditures rose 12702.68% to $22.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $83.8 million, marking a year-over-year increase of 1955.33%. This contributed to the annual value of $71.3 million for FY2025, which is 527.43% down from last year.
  • According to the latest figures from Q4 2025, Nutanix's Capital Expenditures is $22.3 million, which was up 12702.68% from $11.8 million recorded in Q3 2025.
  • In the past 5 years, Nutanix's Capital Expenditures registered a high of $34.6 million during Q1 2025, and its lowest value of $6.8 million during Q1 2022.
  • Its 5-year average for Capital Expenditures is $16.5 million, with a median of $15.2 million in 2022.
  • In the last 5 years, Nutanix's Capital Expenditures plummeted by 5112.81% in 2021 and then surged by 12702.68% in 2025.
  • Nutanix's Capital Expenditures (Quarter) stood at $12.1 million in 2021, then surged by 62.84% to $19.7 million in 2022, then decreased by 23.8% to $15.0 million in 2023, then crashed by 34.52% to $9.8 million in 2024, then surged by 127.03% to $22.3 million in 2025.
  • Its Capital Expenditures was $22.3 million in Q4 2025, compared to $11.8 million in Q3 2025 and $15.1 million in Q2 2025.